(MedicalXpress)- The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines to stop the destructive cascade of changes in the brain that destroys the connections between neurons, leading to memory loss and cognitive decline.
The decade-long study, led by Stuart A. Lipton, M.D., Ph.D., professor and director of the Del E. Webb Center for Neuroscience, Aging, and Stem Cell Research, who is also a practicing clinical neurologist, shows that NitroMemantine can restore synapses, representing the connections between nerve cells (neurons) that have been lost during the progression of Alzheimer's in the brain. The research findings are described in a paper published June 17 by the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
Good News: Experimental drug to boost brain synapses lost in Alzheimer's disease Just For Preview, If You Like Good News: Experimental drug to boost brain synapses lost in Alzheimer's disease Thank for reading http://articles-science-news.blogspot.com/2013/06/good-news-experimental-drug-to-boost.html, and Thank For Visit science news articles.
Posted by , Published at 18.08 and have
0
komentar
Tidak ada komentar:
Posting Komentar